Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 3 Ovarian Neoplasms 2 Neoplasms 2 Endometrial Neoplasms 2 Small Cell Lung Carcinoma 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Carcinoma, Non-Small-Cell Lung 1 Bulbo-Spinal Atrophy, X-Linked 1 Breast Neoplasms 1 Advanced Breast Cancer 1 Adenocarcinoma of Lung 1

Interventions

Fulvestrant 4 trastuzumab deruxtecan 2 elacestrant 2 Vinorelbine 2 AZD9833 2 toripalimab 1 talazoparib 1 ribociclib 1 pyrotinib 1 palbociclib 1 olaparib 1 exemestane 1 eribulin 1 disitamab vedotin 1 dalpiciclib 1 apatinib 1 abemaciclib 1 Selective Estrogen Receptor Modulators 1 Radiotherapy 1 RAD1901 1 Letrozole 1 Injections 1 Gonadotropin-Releasing Hormone 1 Everolimus 1 Capecitabine 1 Aromatase Inhibitors 1 Anastrozole 1 AZD5305 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Advanced Breast Cancer × AZD5305 × Clear all

NCT06380751 2026-05-15

EvoPAR-BR01

AstraZeneca

Phase 3 Recruiting

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡